Tripartite motif 38 alleviates the pathological process of NAFLD–NASH by promoting TAB2 degradation

Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease worldwide, without any Food and Drug Administration-approved pharmacological intervention in clinic. Trim38, as an important member of the TRIM (tripartite motif-containing) family, was largely reported to b...

Full description

Bibliographic Details
Main Authors: Xinxin Yao, Ruixiang Dong, Sha Hu, Zhen Liu, Jie Cui, Fengjiao Hu, Xu Cheng, Xiaoming Wang, Tengfei Ma, Song Tian, Xiao-Jing Zhang, Yufeng Hu, Lan Bai, Hongliang Li, Peng Zhang
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S002222752300055X